K854167 is an FDA 510(k) clearance for the TDX PHENCYCLIDINE. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 5, 1985 after a review of 21 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Abbott Laboratories devices